GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Net Income From Continuing Operations

CBD Life Sciences (CBD Life Sciences) Net Income From Continuing Operations : $-0.10 Mil (TTM As of Sep. 2015)


View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. CBD Life Sciences's net income from continuing operations for the three months ended in Sep. 2015 was $-0.02 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2015 was $-0.10 Mil.

CBD Life Sciences Net Income From Continuing Operations Historical Data

The historical data trend for CBD Life Sciences's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Net Income From Continuing Operations Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Net Income From Continuing Operations
-0.05 -0.16 -0.37 -0.78

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 -0.03 -0.02 -0.03 -0.02

CBD Life Sciences Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences (CBD Life Sciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Net Income From Continuing Operations
Comparable Companies
WAR:UFC TSXV:DXX BOM:532307 QPAG ASX:ICU TSXV:TRAK WAR:SUN BOM:526927 LSE:MNO NGM:CLDR B ASX:RD1 XCNQ:BGRD BOM:532402 ADGO MCCX ASX:OLV WAR:MAD TSXV:FTEC VEII ASX:RXH
Traded in Other Exchanges
N/A
Address
10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259
Website
https://lbcbioscienceinc.com
CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.